{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:59:12Z","timestamp":1778021952189,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Secondary visual loss occurs in millions of patients due to a wound-healing response, known as posterior capsule opacification (PCO), following cataract surgery. An intraocular lens (IOL) is implanted into residual lens tissue, known as the capsular bag, following cataract removal. Standard IOLs allow the anterior and posterior capsules to become physically connected. This places pressure on the IOL and improves contact with the underlying posterior capsule. New open bag IOL designs separate the anterior capsule and posterior capsules and further reduce PCO incidence. It is hypothesised that this results from reduced cytokine availability due to greater irrigation of the bag. We therefore explored the role of growth factor restriction on PCO using human lens cell and tissue culture models. We demonstrate that cytokine dilution, by increasing medium volume, significantly reduced cell coverage in both closed and open capsular bag models. This coincided with reduced cell density and myofibroblast formation. A screen of 27 cytokines identified nine candidates whose expression profile correlated with growth. In particular, VEGF was found to regulate cell survival, growth and myofibroblast formation. VEGF provides a therapeutic target to further manage PCO development and will yield best results when used in conjunction with open bag IOL designs.<\/jats:p>","DOI":"10.1038\/srep24453","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T12:16:52Z","timestamp":1460636212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target"],"prefix":"10.1038","volume":"6","author":[{"given":"Julie A.","family":"Eldred","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S.","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Spalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Michael","family":"Wormstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"BFsrep24453_CR1","first-page":"844","volume":"82","author":"S Resnikoff","year":"2004","unstructured":"Resnikoff, S. et al. Global data on visual impairment in the year 2002. B World Health Organ 82, 844\u2013851, \/S0042-96862004001100009 (2004).","journal-title":"B World Health Organ"},{"key":"BFsrep24453_CR2","first-page":"129","volume":"46","author":"B Thylefors","year":"1998","unstructured":"Thylefors, B. A global initiative for the elimination of avoidable blindness. Indian J Ophthalmology 46, 129\u2013130 (1998).","journal-title":"Indian J Ophthalmology"},{"key":"BFsrep24453_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.exer.2008.10.016","volume":"88","author":"IM Wormstone","year":"2009","unstructured":"Wormstone, I. M., Wang, L. X. & Liu, C. S. C. Posterior capsule opacification. Exp Eye Res 88, 257\u2013269, 10.1016\/j.exer.2008.10.016 (2009).","journal-title":"Exp Eye Res"},{"key":"BFsrep24453_CR4","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.ophtha.2013.04.030","volume":"120","author":"GC Brown","year":"2013","unstructured":"Brown, G. C. et al. Cataract surgery cost utility revisited in 2012: a new economic paradigm. Ophthalmology 120, 2367\u20132376, 10.1016\/j.ophtha.2013.04.030 (2013).","journal-title":"Ophthalmology"},{"key":"BFsrep24453_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2012-302570","volume":"97","author":"D Spalton","year":"2013","unstructured":"Spalton, D. Posterior capsule opacification: have we made a difference? Brit J Ophthalmol 97, 1\u20132, 10.1136\/bjophthalmol-2012-302570 (2013).","journal-title":"Brit J Ophthalmol"},{"key":"BFsrep24453_CR6","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/j.ajo.2009.08.029","volume":"149","author":"B Lundqvist","year":"2010","unstructured":"Lundqvist, B. & Monestam, E. Ten-year longitudinal visual function and Nd: YAG laser capsulotomy rates in patients less than 65 years at cataract surgery. Am J Ophthalmol 149, 238-244 e231, 10.1016\/j.ajo.2009.08.029 (2010).","journal-title":"Am J Ophthalmol"},{"key":"BFsrep24453_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0886-3350(99)80049-2","volume":"25","author":"O Nishi","year":"1999","unstructured":"Nishi, O. & Nishi, K. Preventing posterior capsule opacification by creating a discontinuous sharp bend in the capsule. J Cataract Refract Surg. 25, 521\u2013526 (1999).","journal-title":"J Cataract Refract Surg."},{"key":"BFsrep24453_CR8","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1167\/iovs.14-14364","volume":"55","author":"R Alon","year":"2014","unstructured":"Alon, R., Assia, E. I. & Kleinmann, G. Prevention of posterior capsule opacification by an intracapsular open capsule device. Invest Ophth Vis Sci. 55, 4005\u20134013, 10.1167\/iovs.14-14364 (2014).","journal-title":"Invest Ophth Vis Sci."},{"key":"BFsrep24453_CR9","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1167\/iovs.14-15302","volume":"55","author":"JA Eldred","year":"2014","unstructured":"Eldred, J. A., Spalton, D. J. & Wormstone, I. M. An in vitro evaluation of the Anew Zephyr open-bag IOL in the prevention of posterior capsule opacification using a human capsular bag model. Invest Ophth Vis Sci 55, 7057\u20137064, 10.1167\/iovs.14-15302 (2014).","journal-title":"Invest Ophth Vis Sci"},{"key":"BFsrep24453_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/archopht.1995.01100080112038","volume":"113","author":"T Hara","year":"1995","unstructured":"Hara, T., Hara, T., Sakanishi, K. & Yamada, Y. Efficacy of equator rings in an experimental rabbit study. Arch Ophthalmol 113, 1060\u20131065 (1995).","journal-title":"Arch Ophthalmol"},{"key":"BFsrep24453_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exer.2015.07.009","volume":"142","author":"B Hinz","year":"2016","unstructured":"Hinz, B. Myofibroblasts. Exp Eye Res 142, 56\u201370, 10.1016\/j.exer.2015.07.009 (2016).","journal-title":"Exp Eye Res"},{"key":"BFsrep24453_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ophtha.2005.03.024","volume":"112","author":"K Hayashi","year":"2005","unstructured":"Hayashi, K. & Hayashi, H. Posterior capsule opacification in the presence of an intraocular lens with a sharp versus rounded optic edge. Ophthalmology 112, 1550\u20131556, 10.1016\/j.ophtha.2005.03.024 (2005).","journal-title":"Ophthalmology"},{"key":"BFsrep24453_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jcrs.2007.12.024","volume":"34","author":"MA Nanavaty","year":"2008","unstructured":"Nanavaty, M. A., Spalton, D. J., Boyce, J., Brain, A. & Marshall, J. Edge profile of commercially available square-edged intraocular lenses. J Cataract Refract Surg 34, 677\u2013686, 10.1016\/j.jcrs.2007.12.024 (2008).","journal-title":"J Cataract Refract Surg"},{"key":"BFsrep24453_CR14","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0886-3350(02)01490-6","volume":"28","author":"JF Boyce","year":"2002","unstructured":"Boyce, J. F., Bhermi, G. S., Spalton, D. J. & El-Osta, A. R. Mathematical modeling of the forces between an intraocular lens and the capsule. J Cataract Refract Surg 28, 1853\u20131859 (2002).","journal-title":"J Cataract Refract Surg"},{"key":"BFsrep24453_CR15","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.jcrs.2011.05.049","volume":"37","author":"SC Kavoussi","year":"2011","unstructured":"Kavoussi, S. C. et al. Prevention of capsular bag opacification with a new hydrophilic acrylic disk-shaped intraocular lens. J Cataract Refract Surg 37, 2194\u20132200, 10.1016\/j.jcrs.2011.05.049 (2011).","journal-title":"J Cataract Refract Surg"},{"key":"BFsrep24453_CR16","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jcrs.2012.04.040","volume":"38","author":"L Leishman","year":"2012","unstructured":"Leishman, L. et al. Prevention of capsular bag opacification with a modified hydrophilic acrylic disk-shaped intraocular lens. J Cataract Refract Surg 38, 1664\u20131670, 10.1016\/j.jcrs.2012.04.040 (2012).","journal-title":"J Cataract Refract Surg"},{"key":"BFsrep24453_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/archophthalmol.2011.38","volume":"129","author":"T Hara","year":"2011","unstructured":"Hara, T. et al. Long-term study of posterior capsular opacification prevention with endocapsular equator rings in humans. Arch Ophthalmol 129, 855\u2013863, 10.1001\/archophthalmol.2011.38 (2011).","journal-title":"Arch Ophthalmol"},{"key":"BFsrep24453_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/09031936.00152106","volume":"29","author":"NI Chaudhary","year":"2007","unstructured":"Chaudhary, N. I. et al. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J 29, 976\u2013985, 10.1183\/09031936.00152106 (2007).","journal-title":"Eur Respir J"},{"key":"BFsrep24453_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1006\/clim.2001.5008","volume":"99","author":"PJ Sime","year":"2001","unstructured":"Sime, P. J. & O\u2019Reilly, K. M. A. Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment. Cl Immunol 99, 308\u2013319 (2001).","journal-title":"Cl Immunol"},{"key":"BFsrep24453_CR20","first-page":"169","volume":"10","author":"J Nagata","year":"2002","unstructured":"Nagata, J. et al. Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer. Int J Mol Med 10, 169\u2013172 (2002).","journal-title":"Int J Mol Med"},{"key":"BFsrep24453_CR21","doi-asserted-by":"publisher","first-page":"H1978","DOI":"10.1152\/ajpheart.00414.2003","volume":"286","author":"A Parenti","year":"2004","unstructured":"Parenti, A., Bellik, L., Brogelli, L., Filippi, S. & Ledda, F. Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286, H1978\u20131984, 10.1152\/ajpheart.00414.2003 (2004).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep24453_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1074\/jbc.M110.177006","volume":"286","author":"D Xu","year":"2011","unstructured":"Xu, D., Fuster, M. M., Lawrence, R. & Esko, J. D. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J Biol Chem 286, 737\u2013745, 10.1074\/jbc.M110.177006 (2011).","journal-title":"J Biol Chem"},{"key":"BFsrep24453_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exer.2013.12.004","volume":"120","author":"W Wu","year":"2014","unstructured":"Wu, W. et al. A gradient of matrix-bound FGF-2 and perlecan is available to lens epithelial cells. Exp Eye Res 120, 10\u201314, 10.1016\/j.exer.2013.12.004 (2014).","journal-title":"Exp Eye Res"},{"key":"BFsrep24453_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.exer.2008.08.002","volume":"88","author":"BP Danysh","year":"2009","unstructured":"Danysh, B. P. & Duncan, M. K. The lens capsule. Exp Eye Res 88, 151\u2013164, 10.1016\/j.exer.2008.08.002 (2009).","journal-title":"Exp Eye Res"},{"key":"BFsrep24453_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara, N., Gerber, H. P. & LeCouter, J. The biology of VEGF and its receptors. Nat Med 9, 669\u2013676, 10.1038\/nm0603-669 (2003).","journal-title":"Nat Med"},{"key":"BFsrep24453_CR26","first-page":"5224","volume":"63","author":"D Belotti","year":"2003","unstructured":"Belotti, D. et al. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63, 5224\u20135229 (2003).","journal-title":"Cancer Res"},{"key":"BFsrep24453_CR27","first-page":"2301","volume":"43","author":"IM Wormstone","year":"2002","unstructured":"Wormstone, I. M., Tamiya, S., Anderson, I. & Duncan, G. TGF-beta 2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Investigative Ophthalmology & Visual Science 43, 2301\u20132308 (2002).","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"BFsrep24453_CR28","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1167\/iovs.12-9457","volume":"53","author":"JA Eldred","year":"2012","unstructured":"Eldred, J. A. et al. MMP2 activity is critical for TGFbeta2-induced matrix contraction\u2013implications for fibrosis. Invest Ophth Vis Sci 53, 4085\u20134098, 10.1167\/iovs.12-9457 (2012).","journal-title":"Invest Ophth Vis Sci"},{"key":"BFsrep24453_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11523-009-0126-9","volume":"4","author":"RJ Kelly","year":"2009","unstructured":"Kelly, R. J. & Rixe, O. Axitinib--a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor. Target Oncol 4, 297\u2013305, 10.1007\/s11523-009-0126-9 (2009).","journal-title":"Target Oncol"},{"key":"BFsrep24453_CR30","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery, R. L. et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113, 363\u2013372 e365, 10.1016\/j.ophtha.2005.11.019 (2006).","journal-title":"Ophthalmology"},{"key":"BFsrep24453_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1358\/dot.2014.50.12.2245587","volume":"50","author":"NV Palejwala","year":"2014","unstructured":"Palejwala, N. V. & Lauer, A. K. Aflibercept: an update on recent milestones achieved. Drugs Today 50, 779\u2013790, 10.1358\/dot.2014.50.12.2245587 (2014).","journal-title":"Drugs Today"},{"key":"BFsrep24453_CR32","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00228-014-1755-1","volume":"70","author":"C Biagi","year":"2014","unstructured":"Biagi, C. et al. Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions. Eur J Clin Pharmacol 70, 1505\u20131512, 10.1007\/s00228-014-1755-1 (2014).","journal-title":"Eur J Clin Pharmacol"},{"key":"BFsrep24453_CR33","first-page":"2591","volume":"41","author":"K Ohta","year":"2000","unstructured":"Ohta, K., Yamagami, S., Taylor, A. W. & Streilein, J. W. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophth Vis Sci 41, 2591\u20132599 (2000).","journal-title":"Invest Ophth Vis Sci"},{"key":"BFsrep24453_CR34","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.exer.2006.06.013","volume":"83","author":"IM Wormstone","year":"2006","unstructured":"Wormstone, I. M., Anderson, I. K., Eldred, J. A., Dawes, L. J. & Duncan, G. Short-term exposure to transforming growth factor beta induces long-term fibrotic responses. Exp Eye Res 83, 1238\u20131245, 10.1016\/j.exer.2006.06.013 (2006).","journal-title":"Exp Eye Res"},{"key":"BFsrep24453_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000084508","volume":"179","author":"RU de Iongh","year":"2005","unstructured":"de Iongh, R. U., Wederell, E., Lovicu, F. J. & McAvoy, J. W. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs 179, 43\u201355, 10.1159\/000084508 (2005).","journal-title":"Cells Tissues Organs"},{"key":"BFsrep24453_CR36","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nm0997-1026","volume":"3","author":"G Duncan","year":"1997","unstructured":"Duncan, G., Wormstone, I. M., Liu, C. S., Marcantonio, J. M. & Davies, P. D. Thapsigargin-coated intraocular lenses inhibit human lens cell growth. Nat Med 3, 1026\u20131028 (1997).","journal-title":"Nat Med"},{"key":"BFsrep24453_CR37","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1167\/iovs.06-1345","volume":"48","author":"G Duncan","year":"2007","unstructured":"Duncan, G., Wang, L., Neilson, G. J. & Wormstone, I. M. Lens cell survival after exposure to stress in the closed capsular bag. Invest Ophth Vis Sci 48, 2701\u20132707, 10.1167\/iovs.06-1345 (2007).","journal-title":"Invest Ophth Vis Sci"},{"key":"BFsrep24453_CR38","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1001\/archopht.123.10.1378","volume":"123","author":"AJ Maloof","year":"2005","unstructured":"Maloof, A. J., Pandey, S. K., Neilson, G. & Milverton, E. J. Selective death of lens epithelial cells using demineralized water and Triton X-100 with PerfectCapsule sealed capsule irrigation: a histological study in rabbit eyes. Arch Ophthalmol 123, 1378\u20131384, 123\/10\/1378 [pii] 10.1001\/archopht.123.10.1378 (2005).","journal-title":"Arch Ophthalmol"},{"key":"BFsrep24453_CR39","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/bjo.2006.106468","volume":"91","author":"TM Rabsilber","year":"2007","unstructured":"Rabsilber, T. M., Limberger, I. J., Reuland, A. J., Holzer, M. P. & Auffarth, G. U. Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial. Brit J Ophthalmol 91, 912\u2013915, 10.1136\/bjo.2006.106468 (2007).","journal-title":"Brit J Ophthalmol"},{"key":"BFsrep24453_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/jop.2012.0184","volume":"29","author":"X Huang","year":"2013","unstructured":"Huang, X. et al. Sustained release of 5-fluorouracil from chitosan nanoparticles surface modified intra ocular lens to prevent posterior capsule opacification: an in vitro and in vivo study. J Ocul Pharmacol Th 29, 208\u2013215, 10.1089\/jop.2012.0184 (2013).","journal-title":"J Ocul Pharmacol Th"},{"key":"BFsrep24453_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.colsurfb.2013.05.002","volume":"111","author":"B Amoozgar","year":"2013","unstructured":"Amoozgar, B., Morarescu, D. & Sheardown, H. Sulfadiazine modified PDMS as a model material with the potential for the mitigation of posterior capsule opacification (PCO). Colloid Surface B 111, 15\u201323, 10.1016\/j.colsurfb.2013.05.002 (2013).","journal-title":"Colloid Surface B"},{"key":"BFsrep24453_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/jop.2011.0196","volume":"28","author":"JL Davis","year":"2012","unstructured":"Davis, J. L. et al. Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity. J Ocul Pharmacol Th 28, 359\u2013368, 10.1089\/jop.2011.0196 (2012).","journal-title":"J Ocul Pharmacol Th"},{"key":"BFsrep24453_CR43","doi-asserted-by":"publisher","first-page":"786870","DOI":"10.1155\/2012\/786870","volume":"2012","author":"JL Kovach","year":"2012","unstructured":"Kovach, J. L., Schwartz, S. G., Flynn, H. W. Jr. & Scott, I. U. Anti-VEGF Treatment Strategies for Wet AMD. J Ophthalmol 2012, 786870, 10.1155\/2012\/786870 (2012).","journal-title":"J Ophthalmol"},{"key":"BFsrep24453_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.exer.2003.08.006","volume":"78","author":"IM Wormstone","year":"2004","unstructured":"Wormstone, I. M. et al. Characterisation of TGF-beta 2 signalling and function in a human lens cell line. Exp Eye Res 78, 705\u2013714, 10.1016\/j.exer.2003.08.006 (2004).","journal-title":"Exp Eye Res"},{"key":"BFsrep24453_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.exer.2015.04.021","volume":"142","author":"IM Wormstone","year":"2016","unstructured":"Wormstone, I. M. & Eldred, J. A. Experimental models for posterior capsule opacification research. Exp Eye Res 142, 2\u201312, 10.1016\/j.exer.2015.04.021 (2016).","journal-title":"Exp Eye Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep24453","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:21:07Z","timestamp":1672856467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep24453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,26]]}},"alternative-id":["BFsrep24453"],"URL":"https:\/\/doi.org\/10.1038\/srep24453","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]},"assertion":[{"value":"26 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A.E., M.M., H.S.W. and I.M.W. have no competing interests relating to the work presented. DJS is a consultant to AVS\/Santen and AnewOptic Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24453"}}